Skip to main content
. 2020 Sep 8;11:552102. doi: 10.3389/fphar.2020.552102

Table 2A.

Utilization of certain proton pump inhibitors (PPIs’) over the last 5 years in Hungary (organized in descending order based on the data from 2018)—number of packages.

ATC Active Ingredient 1,000 packages (share in %) trend
2014 2015 2016 2017 2018
A02BC02 pantoprazole 3171.74 3842.92 4144.39 4444.86 4603 graphic file with name fphar-11-552102-g001.jpg
(54.05) (58.22) (60.68) (62.21) (64.60)
A02BC05 esomeprazole 1101.76 1210.43 1241.44 1307.98 1282.82 graphic file with name fphar-11-552102-g002.jpg
(18.78) (18.34) (18.18) (18.31) (18.00)
A02BC04 rabeprazole 768.73 742.15 696.3 673.08 596.48 graphic file with name fphar-11-552102-g003.jpg
(13.10) (11.24) (10.19) (9.42) (8.37)
A02BC03 lansoprazole 630.61 586.23 538.59 495.21 417.06 graphic file with name fphar-11-552102-g004.jpg
(10.75) (8.88) (7.89) (6.93) (5.85)
A02BC01 omeprazole 194.97 218.66 209.74 223.58 225.52 graphic file with name fphar-11-552102-g005.jpg
(3.32) (3.31) (3.07) (3.13) (3.17)
All PPIs (A02AB) 5867.8 6600.4 6830.47 7144.72 7124.88 graphic file with name fphar-11-552102-g006.jpg
(100.00) (100.00) (100.00) (100.00) (100.00)